NRC National Research Corporation
USHealthcareAs of 2026-07-09 16:00
Why NRC matters now
National Research Corporation (NRC) is a US stock in Healthcare. The latest InvestLog snapshot shows $21.71 with -0.73% on the session and $489.3M in market capitalization; recent performance reads 1-month -1.12% and YTD -1.23%.
The latest financial table shown here is Q1 2026, with revenue of $34.8M, net income of $3.2M, and EPS of $0.14. Investors can compare that operating picture with valuation signals such as P/E 33.42 and FCF yield 4.2%.
The latest indexable market news headline is "Constellation Seeks License Renewals for Two New York Units Through 2049" from GuruFocus.
Additional event context on this page matters because analyst consensus is Hold with a median target of $—; recent insider activity includes Rau Jason Russell filing A-Award. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
33.42
PEG
—
P/B
29.95
P/S
3.01
EV/EBITDA
17.70
DCF Value
$13.10
FCF Yield
4.2%
Div Yield
3.0%
Margins & Returns
Gross Margin
55.9%
Operating Margin
14.1%
Net Margin
6.5%
ROE
57.2%
ROA
6.7%
ROIC
12.2%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $34.8M | $3.2M | $0.14 |
| Q4 2025 | $35.2M | $1.8M | $0.08 |
| FY 2025 | $137.4M | $11.6M | $0.52 |
| Q3 2025 | $34.6M | $4.1M | $0.18 |
Analyst Ratings
Consensus
Hold
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Country
US
Exchange
—
Beta
0.40
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.